Hims & Hers Pulls Compounded GLP-1 Pill After FDA Signals Enforcement
Hims & Hers has stopped providing access to a $49 compounded version of Novo Nordisk’s Wegovy after the U.S. Food and Drug Administration said it would take action and restrict GLP-1 ingredients used in compounded drugs. The company paused the offering following conversations with industry stakeholders and regulator warnings that raised questions a…